Today
-4.58%
5 Days
+0.30%
1 Month
+8.34%
6 Months
-0.43%
Year to Date
-19.06%
1 Year
-13.55%
• Blackstone reported strong third-quarter distributable earnings with assets approaching $1.4 trillion. • Strategic AI infrastructure partnerships and capital inflows supported positive investor sentiment. • The stock finished higher despite macroeconomic volatility and neutral technical indicators.
• Blackstone shares experienced sharp volatility and bargain hunting ahead of earnings. • The firm maintains strong fee-related earnings and record assets under management. • Analysts rate the stock as Buy with an average price target.
• Blackstone exited ZO Skin Health for $1.5 billion to Galderma. • The firm is expanding its $200 billion data center empire. • Blackstone reports an annual revenue of $14.87 billion.
• Macroeconomic headwinds and rising Treasury yields pressured alternative asset managers. • Analysts trimmed price targets ahead of the upcoming earnings announcement. • Blackstone reports an annual revenue of $14.87B and net profit of $3.02B.
• Blackstone faced selling pressure from rising Treasury yields and hawkish central bank messaging. • Executive leadership transitions within private equity operations temporarily influenced market sentiment. • Technical indicators show a sell signal with an RSI of 27.600.
• Blackstone reported preliminary realization revenues exceeding three hundred fifty million dollars. • Slower asset sales triggered analyst earnings estimate revisions and institutional selling. • High interest rates and constrained dealmaking created sector-wide headwinds for Blackstone.
Blackstone (BX) Q3 2026 Earnings Call: AUM Reaches $1.4 Trillion


| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.50% |
| BlackRock Institutional Trust Company, N.A. | 4.85% |
| State Street Investment Management (US) | 4.25% |
| Morgan Stanley Smith Barney LLC | 3.60% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 42.47% |
| Investment Advisor/Hedge Fund | 17.77% |
| Research Firm | 4.30% |
| Hedge Fund | 1.89% |
Related Instruments